Cargando…

Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets

The endocannabinoid system (ECS) and the dopaminergic system (DAS) are two major regulators of basal ganglia function. During Huntington's disease (HD) pathogenesis, the expression of genes in both the ECS and DAS is dysregulated. The purpose of this study was to determine the changes that were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laprairie, Robert B, Bagher, Amina M, Precious, Sophie V, Denovan-Wright, Eileen M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317235/ https://www.ncbi.nlm.nih.gov/pubmed/25692022 http://dx.doi.org/10.1002/prp2.104

Ejemplares similares

The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation
por: Young, Alexander P., et al.
Publicado: (2022)

Subfunctionalization of peroxisome proliferator response elements accounts for retention of duplicated fabp1 genes in zebrafish
por: Laprairie, Robert B., et al.
Publicado: (2016)

Promoters Are Differentially Sensitive to N-Terminal Mutant Huntingtin-Mediated Transcriptional Repression
por: Hogel, Matthew, et al.
Publicado: (2012)

Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
por: Kibret, Berhanu Geresu, et al.
Publicado: (2023)

Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation
por: Rangel-Barajas, Claudia, et al.
Publicado: (2016)

13. ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
por: Bloomfield, Michael
Publicado: (2018)

The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review
por: Bagher, Amina M.
Publicado: (2021)

Endocannabinoid–Dopamine Interactions in Striatal Synaptic Plasticity
por: Mathur, Brian N., et al.
Publicado: (2012)

13.1 ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
por: Moreira, Fabricio
Publicado: (2018)

Endocannabinoids and Dopamine Balance Basal Ganglia Output
por: Gorodetski, Lilach, et al.
Publicado: (2021)

Prevalence of methylenetetrahydrofolate reductase gene polymorphisms (C677T, and A1298C) among Saudi children receiving dental treatment
por: Bagher, Amina M., et al.
Publicado: (2021)

To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making
por: Hernandez, Giovanni, et al.
Publicado: (2015)

Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
por: Melis, M, et al.
Publicado: (2007)

Endocannabinoid Modulation of Nucleus Accumbens Microcircuitry and Terminal Dopamine Release
por: Covey, Dan P., et al.
Publicado: (2021)

Microbial Metabolic Genes Crucial for S. aureus Biofilms: An Insight From Re-analysis of Publicly Available Microarray Datasets
por: Nassar, Rania, et al.
Publicado: (2021)

The Role of Dopamine and Glutamate Modulation in Huntington Disease
por: Mittal, Sumeer K., et al.
Publicado: (2013)

Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013)

Dopamine–endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum
por: Xu, Hao, et al.
Publicado: (2018)

Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction
por: Luján, Miguel Á., et al.
Publicado: (2023)

Clinical Availability of Component-Resolved Diagnosis Using Microarray Technology in Atopic Dermatitis
por: Choi, Joon-Seok, et al.
Publicado: (2014)

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
por: Boorman, Emily, et al.
Publicado: (2015)

Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans
por: Permyakova, Anna, et al.
Publicado: (2023)

Endocannabinoid System Components as Potential Biomarkers in Psychiatry
por: Navarrete, Francisco, et al.
Publicado: (2020)

Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling
por: Laprairie, Robert B., et al.
Publicado: (2019)

Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction
por: Sagheddu, Claudia, et al.
Publicado: (2020)

The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption
por: Ding, Weihua, et al.
Publicado: (2023)

Phosphoproteomic dysregulation in Huntington’s disease mice is rescued by environmental enrichment
por: Mees, Isaline, et al.
Publicado: (2022)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities
por: Grabiec, Urszula, et al.
Publicado: (2017)

The role of dopamine and endocannabinoid systems in prefrontal cortex development: Adolescence as a critical period
por: Peters, Kate Zara, et al.
Publicado: (2022)

Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex
por: Lafourcade, Mathieu, et al.
Publicado: (2007)

Characterisation and localisation of the endocannabinoid system components in the adult human testis
por: Nielsen, John E., et al.
Publicado: (2019)

Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus
por: Bhat, Vishweshwara, et al.
Publicado: (2023)

Transcriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways
por: Plantier, Laurent, et al.
Publicado: (2016)

Dopamine System Dysregulation in Major Depressive Disorders
por: Belujon, Pauline, et al.
Publicado: (2017)

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020)

Dopamine dysregulation syndrome after prescription of dopamine agonists: a case report
por: Costa, M.L., et al.
Publicado: (2022)

Analysis workflow of publicly available RNA-sequencing datasets
por: Sanchis, Pablo, et al.
Publicado: (2021)

Publicly Available Health Research Datasets: Opportunities and Responsibilities
por: BaHammam, Ahmed S, et al.
Publicado: (2022)

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
por: Chen, Jane Y., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3a3ne28hi2r7ajlnh6pt50c98i